ARandomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Vardenafil 10 mg Twice Daily to Assess the Effect on Urodynamics in Patients With Overactive Bladder (Detrusor Overactivity)
Latest Information Update: 29 Dec 2021
At a glance
- Drugs Vardenafil (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Bayer; Bayer HealthCare
- 15 Jun 2019 This trial has been completed in Spain, according to European Clinical Trials Database.
- 13 Feb 2013 New source identified and integrated (German Clinical Trials Register: DRKS00004129).
- 09 Feb 2010 Additional trial locations (Canada, Switzerland) identified as reported by ClinicalTrials.gov.